Immuneering Corp. (IMRX)
4.43
+0.30
(+7.13%)
USD |
NASDAQ |
Jan 14, 16:00
4.44
+0.01
(+0.23%)
After-Hours: 20:00
Immuneering Market Cap: 286.05M for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 48.47B |
| Regeneron Pharmaceuticals, Inc. | 79.26B |
| Vanda Pharmaceuticals, Inc. | 455.04M |
| Verastem, Inc. | 511.42M |
| Fortress Biotech, Inc. | 101.80M |
Market Cap Related Metrics
| Price to Book Value | 1.255 |
| Price | 4.43 |
| Earnings Yield | -40.25% |